Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6414)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 14, 2021 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li M, Shang H, Wang T, Yang SQ, Li L. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression. World J Gastroenterol 2021; 27(10): 939-958 [PMID: 33776365 DOI: 10.3748/wjg.v27.i10.939] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i10/939.htm |
| Number | Citing Articles |
| 1 |
Zhiyun Zhang, Jian Wang, Weiping Wan, Zhengchao Shen, Aixue Zuo, Rong Chen, Qinyi Wu, Enli Cai, Feng Huang, Rongping Zhang, Xinan Shi. Stigmast-4-en-6β-ol-3-one decreases viability and induces apoptosis and ferroptosis in liver cancer cells by reducing E2F1. Animal Cells and Systems 2023; 27(1): 340 doi: 10.1080/19768354.2023.2282224
|
| 2 |
Li Huang, Lier Lin, Xiangjun Fu, Can Meng. Development and validation of a novel survival model for acute myeloid leukemia based on autophagy-related genes. PeerJ 2021; 9: e11968 doi: 10.7717/peerj.11968
|
| 3 |
Jianbin Wu, Mingmin Luo, Zhuangwei Chen, Lei Li, Xiaoxi Huang. Integrated Analysis of the Expression Characteristics, Prognostic Value, and Immune Characteristics of PPARG in Breast Cancer. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.737656
|
| 4 |
Yi Li, Yuanxiu Leng, Yudi Dong, Yongxiang Song, Qiaoyuan Wu, Ni Jiang, Hui Dong, Fang Chen, Qing Luo, Chen Cheng. Cyclin B1 expression as an independent prognostic factor for lung adenocarcinoma and its potential pathways. Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13561
|
| 5 |
Romina Mehdizadeh, Alireza Madjid Ansari, Flora Forouzesh, Fatemeh Shahriari, Seyed Peyman Shariatpanahi, Ali Salaritabar, Mohammad Amin Javidi. P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-38021-z
|
| 6 |
Yi Wang, Zhongshi Hong, Jintian Song, Peilin Zhong, Liang Lin. METTL3 promotes drug resistance to oxaliplatin in gastric cancer cells through DNA repair pathway. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1257410
|
| 7 |
Haiyan Li, Fuchu Qian, Shengjie Bao. Identification and functional analysis of lactic acid metabolism-related differentially expressed genes in hepatocellular carcinoma. Frontiers in Genetics 2024; 15 doi: 10.3389/fgene.2024.1390882
|
| 8 |
Sheryl Rodriguez, Kristy Skeet, Tugba Mehmetoglu-Gurbuz, Madeline Goldfarb, Shri Karri, Jackelyn Rocha, Mark Shahinian, Abdallah Yazadi, Seeta Poudel, Ramadevi Subramani. Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma. Cancers 2021; 13(22): 5753 doi: 10.3390/cancers13225753
|
| 9 |
Bin Xiang, Mei-Lin Chen, Zhi-Qiang Gao, Tao Mi, Qin-Lin Shi, Jun-Jun Dong, Xiao-Mao Tian, Feng Liu, Guang-Hui Wei. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor. BMC Medical Genomics 2023; 16(1) doi: 10.1186/s12920-023-01627-3
|
| 10 |
Min-Hua Rong, Jian-Di Li, Lu-Yang Zhong, Yu-Zhen Huang, Juan Chen, Li-Yuan Xie, Rong-Xing Qin, Xiao-Lian He, Zhan-Hui Zhu, Su-Ning Huang, Xian-Guo Zhou. CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. Experimental Biology and Medicine 2022; 247(5): 395 doi: 10.1177/15353702211049149
|
| 11 |
Xu Xinyi, Liu Leping, Cao Xueshuai, Long Xi, Peng Sujuan, Zhang Guomin. Network pharmacology and molecular docking analysis on molecular targets and mechanism prediction of Huanglian Jiedu Decoction in the treatment of COVID-19. Digital Chinese Medicine 2022; 5(1): 18 doi: 10.1016/j.dcmed.2022.03.003
|
| 12 |
LIAN HU, LINLIN LI, HONG CHE, BINGJIE ZHAO, LI XIAO, PEIJIA LIU, WENJING YI, SONGSHAN LIU. Huanglian Decoction treats Henoch-Schonlein purpura nephritis by inhibiting NF-κB/NLRP3 signaling pathway and reducing renal IgA deposition. Anais da Academia Brasileira de Ciências 2024; 96(1) doi: 10.1590/0001-3765202420220970
|